FDA BLA · BLA761349
COSENTYX
secukinumab
Sponsor: NOVARTIS PHARMS CORP
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
BLA761349
TYPE
BLA
ORIGINAL APPROVAL
2023-10-06
LATEST ACTION
2026-10-15
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
COSENTYXPrescription
SECUKINUMAB 150MG · INJECTABLE · INJECTION
Approval history
2024-04-04Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →